Abstract
The concurrent administration of Metrazol (60 mg/kg, i.v.) to anaesthetized rats enhances the cerebral penetration of the anticancer agent razoxane. Such an enhancement leads to an increase in the therapeutic efficacy of razoxane against intracerebrally sequestered L1210 leukaemia cells in mice. The combination of Metrazol and melphalan was also examined to see if the concentration of other anticancer agents in CSF could be enhanced.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blasberg, R., Gazendam, J., Patlak, C., Shapiro, W., and Fenstermacher, J., 1980, Changes in blood-brain transfer parameters induced by hyperosmolar intracarotid infusion and by metastatic tumour growth. Cerebral Microvasculature, edited by H. Eisenberg and R. Suddith (New York: Plenum Press), pp. 307–319.
Bradbury, M., 1979, Concept of a Blood- Brain Barrier (Chichester, New York: John Wiley).
Chang, S., Alberts, D., Melnick, L., Walson, P., and Salmon, S., 1978. High-pressure liquid chromatographic analysis of melphalan in plasma. Journal of Pharmaceutical Science, 67, 679–682.
Crone, C., 1965, Permeability of brain capillaries to non electrolytes. Acta Physiologica Scandinavica, 64, 407–417.
Greig, N., Fu, X., and Hellmann, K., 1982, Razoxane penetration into the cerebrospinal fluid of rats. Cancer Chemotherapy and Pharmacology, 8, 251–252.
Greig, N., and Hellmann, K., 1983, Enhanced cerebrovascular permeability by metrazol: Significance for brain metastases. Clinical and Experimental Metastasis, 1, 83–95.
Greig, N., Jones, H., and Cavanagh, J., 1983, Blood-brain barrier integrity and host responses in experimental metastatic brain tumours. Clinical and Experimental Metastasis, 1, 229–246.
Herman, E. H., Witiak, D. T., Hellmann, K., and Waravdekar, V. S., Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds. Advances in Pharmacology and Chemotherapy, Volume 19 (New York: Plenum Press), pp. 249–290.
Hoshino, T., Barker, M., and Wilson, C., 1972, Cell kinetics of human gliomas. Journal of Neurosurgery, 37, 15–26.
Levin, V. A., 1975, A pharmacological basis of brain tumour chemotherapy. Seminars in Oncology, 2, 57–61.
Levin, V., Freeman-Dove, M., and Landahl, H., 1975, The permeability characteristics of brain adjacent to tumours in rats. Archives of Neurology, 32, 785–791.
Lorenzo, A., SShirahige, M., Lang, M., and Barlow, C., 1972, Temporary alteration of cerebrovascular permeability to plasma proteins in drug-induced seizures. American Journal of Physiology, 223, 268–277.
NCI Protocols, 1962, Cancer Chemotherapy Reports, 25.
Ohno, K., Fredericks, W., and Rapoport, S., 1979, Osmotic opening of the bloodbrain barrier to methotrexate in the rat. Surgical Neurology, 12, 323–328.
Rapoport, S., 1976, Blood-brain Barrier in Physiology and Medicine (New York: Raven Press).
Rapoport, S., 1980, Quantitative aspects of osmotic opening of the blood-brain barrier. Brain Metastasis, edited by L. Weiss, H. Gilbert and J. Posner (Boston: Hall & Co.).
Reese, T., and Karnovsky, M., 1967, Fine structural localization of a blood-brain barrier to exogenous peroxidase. Journal of Cell Biology, 34, 207–217.
Venditti, J., 1971, Treatment schedule dependence of experimentally active antileukaemic (L1210) drugs. Cancer Chemotherapy Reports, Part 2, 35–59.
Walker, M., 1977, Treatment of brain tumours. Medical Clinics of North America, 61, 1045–1051.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greig, N., Newell, D. & Hellmann, K. Short communication: Metrazol enhances brain penetration and therapeutic efficacy of some anticancer agents: implications for brain metastases. Clin Exp Metast 2, 55–59 (1984). https://doi.org/10.1007/BF00132306
Issue Date:
DOI: https://doi.org/10.1007/BF00132306